Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Viemed Healthcare, Inc. (VMD : NSDQ)

• Company Description    Viemed Healthcare Inc. is a home medical equipment supplier which provides post-acute respiratory care services through its subsidiaries Sleep Management L.L.C. and Home Sleep Delivered L.L.C. Viemed Healthcare Inc. is based in Lafayette, United States. Number of Employees: 1,179

• Price / Volume Information    Yesterday's Closing Price: $6.92 Daily Weekly Monthly 20 Day Moving Average: 218,307 shares Shares Outstanding: 38.79 (millions) Market Capitalization: $268.40 (millions) Beta: 1.38 52 Week High: $9.81 52 Week Low: $5.93 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.44% -1.38% 12 Week 5.17% -4.52% Year To Date -13.72% -22.96%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 625 East Kaliste Saloom Road - Lafayette,LA 70508 USA ph: 337-504-3802 fax: - glen@bristolir.com http://www.viemed.com

• General Corporate Information    Officers Casey Hoyt - Chief Executive Officer Randy Dobbs - Chairman W. Todd Zehnder - Chief Operating Officer Trae Fitzgerald - Chief Financial Officer William Frazier - Director Peer Information Viemed Healthcare, Inc. (BJCT) Viemed Healthcare, Inc. (CADMQ) Viemed Healthcare, Inc. (APNO) Viemed Healthcare, Inc. (UPDC) Viemed Healthcare, Inc. (IMTIQ) Viemed Healthcare, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 92663R105 SIC: 8090 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/05/25 Share - Related Items Shares Outstanding: 38.79 Most Recent Split Date: (:1) Beta: 1.38 Market Capitalization: $268.40 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/05/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 20.35 PEG Ratio: - Price Ratios Price/Book: 1.94 Price/Cash Flow: 7.35 Price / Sales: 1.11 EPS Growth vs. Year Ago Period: 100.00% vs. Previous Quarter: 33.33% Sales Growth vs. Year Ago Period: 14.72% vs. Previous Quarter: 6.64% ROE 06/30/25 - 10.38 03/31/25 - 9.49 12/31/24 - 9.06 ROA 06/30/25 - 7.88 03/31/25 - 7.14 12/31/24 - 6.77 Current Ratio 06/30/25 - 1.48 03/31/25 - 1.38 12/31/24 - 1.42 Quick Ratio 06/30/25 - 1.37 03/31/25 - 1.26 12/31/24 - 1.30 Operating Margin 06/30/25 - 5.80 03/31/25 - 5.28 12/31/24 - 5.02 Net Margin 06/30/25 - 5.80 03/31/25 - 5.28 12/31/24 - 5.02 Pre-Tax Margin 06/30/25 - 8.48 03/31/25 - 7.61 12/31/24 - 7.21 Book Value 06/30/25 - 3.58 03/31/25 - 3.46 12/31/24 - 3.41 Inventory Turnover 06/30/25 - 22.99 03/31/25 - 21.89 12/31/24 - 20.93 Debt-to-Equity 06/30/25 - 0.02 03/31/25 - 0.03 12/31/24 - 0.03 Debt-to-Capital 06/30/25 - 2.39 03/31/25 - 2.52 12/31/24 - 2.62

Powered by Zacks Investment Research ©